Penumbra Inc

In-House Clinical Research Associate II

United States

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical Devices, Clinical ResearchIndustries

Requirements

Candidates should possess a Bachelor’s degree in Biological Sciences or a related field, such as Biology, Chemistry, Biochemistry, Nursing, Biomedical, or Veterinary Sciences, along with a minimum of 3 years of experience in clinical or scientific research, nursing, or a comparable combination of education and experience. Basic knowledge of medical terminology is required, and familiarity with laws, regulations, standards, and guidance governing clinical studies is preferred. Strong computer skills, including experience with spreadsheets and word processing programs, are also necessary.

Responsibilities

The In-House Clinical Research Associate II will draft study-specific informed consent templates, assist with developing and maintaining project timelines, prepare routine operations reports, and support the study start-up process across multiple studies, including ICF review, budget negotiation, and assisting clinical sites with IRB submissions. They will also drive study amendment and closeout activities, motivate clinical sites to meet study endpoints, provide support to Project Management in establishing clinical trial management processes, collaborate with the Clinical Field team to improve site activation, distribute and track regulatory documentation, assist with the development and maintenance of clinical infrastructure, provide updates to management regarding site progress, participate in audits, adhere to the Company’s Quality Management System, and perform other work-related duties as assigned.

Skills

Clinical Study Management
Regulatory Documentation
IRB Submission
Study Protocols
Informed Consent Drafting
Project Coordination
Audit Preparation
SOP Development

Penumbra Inc

Develops medical devices for vascular conditions

About Penumbra Inc

Penumbra Inc. specializes in creating medical devices aimed at treating neurovascular and peripheral vascular conditions. Their products, such as the Penumbra System and the Indigo System, are designed for use in hospitals and clinics, helping healthcare professionals address issues like stroke and other vascular diseases. These devices work by providing advanced tools for interventions in neurology and vascular surgery, allowing for effective treatment options. Unlike many competitors, Penumbra focuses specifically on these specialized areas, ensuring their products are tailored to the needs of medical professionals in these fields. The company's goal is to continuously improve and innovate their medical devices to enhance patient care and support healthcare providers in delivering effective treatments.

Alameda, CaliforniaHeadquarters
2004Year Founded
$116.7KTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Parental Leave
Paid Vacation
Paid Sick Leave
Paid Holidays

Risks

Recent layoffs in the Immersive Healthcare division may indicate financial strain.
The EMBOLIZE trial could divert resources from core product lines.
Regulatory challenges in Europe may impact sales of new products like BMX81 and BMX96.

Differentiation

Penumbra offers a comprehensive range of neuro and peripheral vascular devices.
The company focuses on innovative solutions for stroke and neurovascular disease treatment.
Penumbra's global presence spans North America, Europe, Asia, and Australia.

Upsides

Growing demand for minimally invasive procedures aligns with Penumbra's product offerings.
The global neurovascular devices market is projected to grow at 8.5% CAGR until 2030.
Penumbra's European launch of BMX81 and BMX96 expands its market presence.

Land your dream remote job 3x faster with AI